Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Reliable detection of heart disease and allergies

02.06.2008
The synlab medical laboratory in Nuremberg is the 5000th customer to purchase the Immulite 2000 Analyzer from Siemens

synlab Nuremberg has put the five thousandth Immulite 2000 Analyzer sold by Siemens worldwide into operation. Franconia's largest laboratory center serves some 1,000 physicians and nine clinics in the region. synlab will primarily use the Immulite 2000 Diagnostic System to test blood and serum samples for heart disease and allergies.


"With the Immulite 2000 from Siemens, we now have one of the most efficient immunoassay analyzers currently on the market", said Alexander Hoffmann, CEO of MVZ synlab Nuremberg. "What I especially appreciate about this device is its outstanding sensitivity and the fact that all process steps from pipetting, incubation, reading the sample and evaluation are fully automated. The personnel capacity required to process samples is thus lower than before."

"We are pleased that we were able to extend our cooperation with synlab. We are convinced that, with their wide spectrum of parameters, our immunoassay systems will make an important contribution to improving health", said Stefan Wolf, Regional Vice President EMEA I und General Manager of Siemens Healthcare Diagnostics in Germany. "Believe it or not, 70 percent of all clinical decisions made by physicians are based on the results of in vitro examinations, however, only two percent of all health-related expenditures are invested in this area. That clearly underscores the benefits that laboratory diagnostics yield for healthcare!" Siemens is the global market leader in immunoassay systems.

Siemens analytical systems contribute to the improvement of healthcare throughout the world and help to detect diseases in an early stage as well as to monitor the course of diseases. The Immulite 2000 is an analytical system for medical diagnostic laboratories that can be used to perform automated tests. This device is one of the most versatile immunoassay systems available on the international laboratory diagnostics market. For example, it can be used to test 450 different allergens. One of its special features is an innvotive patient test for diagnosing sepsis and cardiological diseases. This device has been on the market since 1998, and is now in operation in almost 200 countries worldwide.

synlab Nuremberg offers the entire spectrum of modern laboratory medicine to the physicians of Central Franconia. The focus is on STD diagnostics and gynecological endocrinology. Sample pick-up and report transfer services tailored to the needs of customer practices are understood as the basis for synlab laboratory services. Support of the Central Franconian regional company is provided at Fuerther Strasse 212; some 80 qualified medical employees are employed at Rohrmannstr. 12.

Siemens Healthcare is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion.

Marion Bludszuweit | Siemens Healthcare
Further information:
http://www.siemens.com/healthcare
http://www.synlab.de

More articles from Medical Engineering:

nachricht MoreGrasp: significant research results in the field of thought-controlled grasp neuroprosthetics
17.09.2018 | Technische Universität Graz

nachricht Wearable ultrasound patch monitors blood pressure deep inside body
13.09.2018 | University of California - San Diego

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists present new observations to understand the phase transition in quantum chromodynamics

The building blocks of matter in our universe were formed in the first 10 microseconds of its existence, according to the currently accepted scientific picture. After the Big Bang about 13.7 billion years ago, matter consisted mainly of quarks and gluons, two types of elementary particles whose interactions are governed by quantum chromodynamics (QCD), the theory of strong interaction. In the early universe, these particles moved (nearly) freely in a quark-gluon plasma.

This is a joint press release of University Muenster and Heidelberg as well as the GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt.

Then, in a phase transition, they combined and formed hadrons, among them the building blocks of atomic nuclei, protons and neutrons. In the current issue of...

Im Focus: Patented nanostructure for solar cells: Rough optics, smooth surface

Thin-film solar cells made of crystalline silicon are inexpensive and achieve efficiencies of a good 14 percent. However, they could do even better if their shiny surfaces reflected less light. A team led by Prof. Christiane Becker from the Helmholtz-Zentrum Berlin (HZB) has now patented a sophisticated new solution to this problem.

"It is not enough simply to bring more light into the cell," says Christiane Becker. Such surface structures can even ultimately reduce the efficiency by...

Im Focus: New soft coral species discovered in Panama

A study in the journal Bulletin of Marine Science describes a new, blood-red species of octocoral found in Panama. The species in the genus Thesea was discovered in the threatened low-light reef environment on Hannibal Bank, 60 kilometers off mainland Pacific Panama, by researchers at the Smithsonian Tropical Research Institute in Panama (STRI) and the Centro de Investigación en Ciencias del Mar y Limnología (CIMAR) at the University of Costa Rica.

Scientists established the new species, Thesea dalioi, by comparing its physical traits, such as branch thickness and the bright red colony color, with the...

Im Focus: New devices based on rust could reduce excess heat in computers

Physicists explore long-distance information transmission in antiferromagnetic iron oxide

Scientists have succeeded in observing the first long-distance transfer of information in a magnetic group of materials known as antiferromagnets.

Im Focus: Finding Nemo's genes

An international team of researchers has mapped Nemo's genome

An international team of researchers has mapped Nemo's genome, providing the research community with an invaluable resource to decode the response of fish to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

One of the world’s most prominent strategic forums for global health held in Berlin in October 2018

03.09.2018 | Event News

4th Intelligent Materials - European Symposium on Intelligent Materials

27.08.2018 | Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

 
Latest News

Fraunhofer ISE with over 60 Contributions at the European PV Solar Energy Conference and Exhibition

21.09.2018 | Trade Fair News

558 million-year-old fat reveals earliest known animal

21.09.2018 | Earth Sciences

Neutrons produce first direct 3D maps of water during cell membrane fusion

21.09.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>